Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies

The need for high-affinity, SARS-CoV-2-specific monoclonal antibodies (mAbs) is critical in the face of the global COVID-19 pandemic, as such reagents can have important diagnostic, research, and therapeutic applications. Of greatest interest is the ~ 300 amino acid receptor binding domain (RBD) wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Chapman, Asheley P., Tang, Xiaoling, Lee, Joo R., Chida, Asiya, Mercer, Kristina, Wharton, Rebekah E., Kainulainen, Markus, Harcourt, Jennifer L., Martines, Roosecelis B., Schroeder, Michelle, Zhao, Liangjun, Bryksin, Anton, Zhou, Bin, Bergeron, Eric, Bollweg, Brigid C., Tamin, Azaibi, Thornburg, Natalie, Wentworth, David E., Petway, David, Bagarozzi, Dennis A., Finn, M. G., Goldstein, Jason M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102525/
https://ncbi.nlm.nih.gov/pubmed/33958613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88809-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars